Insights Widest with the analysis, Proactive gives perspectives that others don't.

cannabis plants Zoetic International makes rapid progress with CBD business

Zoetic grows its own hemp and sells CBD products in the US and the UK

4 days, 20 hours ago

Why the coronavirus crisis might not be as bad as 2008; and why it might be...

Markets are pausing for breath, trying to work out what's coming next

1 week, 2 days ago
Deep dive

Zelira Therapeutics accelerates towards commercialisation in 2020

The global therapeutic medicinal cannabis company owns a portfolio of proprietary products...

1 week, 3 days ago
Deep dive

Admedus encouraged by smooth start to new sales model, including first major...

The debut of Admedus' innovation suite at the world’s largest structural heart valve congress,...

on 31/1/20
Deep dive

Cellmid takes on aging with both consumer products and pharmaceuticals

Cellmid Ltd (ASX:CDY) is a life sciences company focused on developing solutions for conditions...

on 19/12/19


Full interview: Zelira Therapeutics releases interim data for Phase II...

Zelira Therapeutics Ltd (ASX:ZLD) managing director Dr Richard Hopkins, chairman Osagie Imasogie and clinical trial principal investigator Professor Peter Eastwood, of the University of Western Australia, update Proactive on results from the company’s Phase II clinical trial of medicinal...

on 21/2/20

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.